Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia: The INSPIRES Randomized Clinical Trial
Ying Gao,Lingling Jiang,Yuesong Pan,Weiqi Chen,Jing Jing,Chunjuan Wang,S Claiborne Johnston,Pierre Amarenco,Philip M Bath,Yingying Yang,Tingting Wang,Shangrong Han,Xia Meng,Jinxi Lin,Xingquan Zhao,Liping Liu,Jinguo Zhao,Ying Li,Yingzhuo Zang,Shuo Zhang,Hongqin Yang,Jianbo Yang,Yuanwei Wang,Dali Li,Yanxia Wang,Dongqi Liu,Guangming Kang,Yongjun Wang,Yilong Wang,INSPIRES Investigators,Zhimin Wang N/A,Jianmin Guo N/A,Xiujuan Song N/A,Xinqiang Wang N/A,Weifeng Lu N/A,Panbing Huang N/A,Feng Li N/A,Lihua Wang N/A,Weigang Xiao N/A,Yibin Cao N/A,Liangqun Rong N/A,Ying Xing N/A,Lili Ma N/A,Yanhua Zhou N/A,YuQing Han N/A,Jingxian Fang N/A,Jie Liu N/A,Wen Shangguan N/A,Bin Liu N/A,Jianhua Li N/A,Yan Han N/A,Chengguang Song N/A,Xuhong Song N/A,Yuanfeng Lv N/A,Changqing Xu N/A,Congmin Ma N/A,Zhihui Duan N/A,Yungao Pan N/A,Lijie Ren N/A,Bin Li N/A,Jinqi Fan N/A,Yuanren Zhang N/A,Jingfang Li N/A,Baojun Wang N/A,Jun Gu N/A,Xiaoping Yin N/A,Xiao Wang N/A,Liguo Chang N/A,Kaoling Gong N/A,Wenhua Zhang N/A,Yu Che N/A,Yinyuan Wan N/A,Linying Gui N/A,Ping Sun N/A,Zhonghai Jia N/A,Haichao Liu N/A,Qinglian Meng N/A,Donghe Chai N/A,Lei Zhang N/A,Guofeng Li N/A,Huafeng Jin N/A,Gexia Liu N/A,Yonghong Tang N/A,Xiaomin Mei N/A,Guoping Zou N/A,Yuefeng Yang N/A,Quanhao Li N/A,Xiju Tian N/A,Hong Chen N/A,Jialiang Xiao N/A,Xiaoming Song N/A,Guangning Li N/A,Guozhong Li N/A,Chunjie Yang N/A,Xiting Zhang N/A,Chun Wang N/A,Jizheng Hu N/A,Wei Hu N/A,Zhen Jiao N/A,Yunnan Lu N/A,Zhangyong Xia N/A,Yufen Wang N/A,Yinshan Wang N/A,Jinxing Qi N/A,Xiaoping Wang N/A,Shuqin Liu N/A,Bo Li N/A,Yinghui Li N/A,Yaming Sun N/A,Ping Jing N/A,Jialing Wu N/A,Bo Yang N/A,Jinghua Zhang N/A,Tianxia Zhang N/A,Chunling Zheng N/A,Lejun Li N/A,Huimin Li N/A,Fumin Yu N/A,Shufang Yao N/A,Jianjun Chang N/A,Dongqun Li N/A,Ganqin Du N/A,Yi Zhao N/A,Pengfei Liang N/A,Ming Wang N/A,Qi Fang N/A,Youqing Deng N/A,Xuzhao Gao N/A,Runxiu Zhu N/A,Yimin Xie N/A,Yanshu Liu N/A,Yi Yuan N/A,Qiuyi Wu N/A,Guimei Zhao N/A,Yan Yang N/A,Yong Lu N/A,Weidong Zhao N/A,Tianbao Chen N/A,Deng Pan N/A,Min Yang N/A,Baoguo Xue N/A,Ge Zhang N/A,Yanjiang Zhao N/A,Yunfei Wei N/A,Wenwei Yun N/A,Xiaoqi Chen N/A,Danhong Wu N/A,Lifang Zhang N/A,Baoying Sheng N/A,Zhigang Cui N/A,Xiangdong Xie N/A,Guanghui Cheng N/A,Yifei Zhang N/A,Ruiming Zhu N/A,Yong Chen N/A,GuoHua Liu N/A,Lei Feng N/A,Zhihua Long N/A,Huisheng Chen N/A,Ping Zhang N/A,Yuanliang Cui N/A,Yongli Zhang N/A,Yazhou Han N/A,Yajie Bai N/A,Tieyu Tang N/A,Songdi Wu N/A,Wenping Gong N/A,Jun Wang N/A,Zhishan Zhu N/A,Xiaoyan Ma N/A,Leyi Yao N/A,Runhui Li N/A,Shuanggen Zhu N/A,Juntao Li N/A,Xiuhui Qi N/A,Zhongping Jiang N/A,Zhigang Liang N/A,Chunping Liu N/A,Dongjuan Xu N/A,Tao Qiu N/A,Chunping Chen N/A,Hong Tan N/A,Shengli Chen N/A,Chunshui Yang N/A,Wei Jun N/A,Qing He N/A,Zengqiang Sun N/A,Shen Li N/A,Cunju Guo N/A,Hongliang Wang N/A,Dongfang Li N/A,Hongbin Wu N/A,Wenxu Zhen N/A,Lijun Wang N/A,Wenke Hong N/A,Xuerong Qiu N/A,Xinxia Wei N/A,Yongtao Lv N/A,Xiangyang Feng N/A,Gaiqing Yang N/A,Songjun Lin N/A,Aihua Cao N/A,Dejin Sun N/A,Pengcheng Fu N/A,Cao Cao N/A,Wenjun Xue N/A,Haiyan Liu N/A,Shanshan Li N/A,Fang Qu N/A,Zhengguo Zhou N/A,Ping Liu N/A,Lixia Wang N/A,Yiping Wu N/A,Jinxing Liu N/A,Xin Sun N/A,Qingyong Wang N/A,Xiaomei Li N/A,Qizhang Wang N/A,Yongxiong Wu N/A,Chunfeng Liu N/A,Yanxin Zhao N/A,Zhijian Lin N/A,Rui Ma N/A,Jiedan Li N/A,Zhishun Zhu N/A,Lili Guo N/A,Bing Sun N/A,Jun Tan N/A,Ke Yang N/A,Yong Bi N/A,Yingjie Duan N/A,Shaochun Li N/A,Xiaoliang Lou N/A,Xiaosong Huang N/A,Fucai Zang N/A,Yonghua Dong N/A,Jingyan Zhao N/A,Yanzeng Cui N/A,Zili Zhang N/A,Yali Zhang N/A,Peng Yan N/A,Huixian Fan N/A,Qiuhong Ji N/A,Aisheng Wu N/A,Xinshen Han N/A,Li Liu N/A,Jie Song N/A,Shuting Liu N/A,Xiaoyu Che N/A,Xianhong Liang N/A,Shangzhi Li N/A,Nan Qi N/A,Xiaolei Chen N/A,Chenhui Liu N/A,Jingtao Pi N/A,Yu Tian N/A,Nan Wang N/A,Zhengyang Li N/A,Biyang Luo N/A,Fanfang Yue N/A,Lei Guo N/A,Kun Hu N/A,Xi Zhong N/A,Jiawei Lu N/A,Long Wang N/A,Jiandong Yu N/A,Xiaowu Zhang N/A,Mengyuan Zhou N/A,Yiyi Chen N/A,Zhiyuan Ji N/A,Jianying Li N/A,Hongyi Yan N/A,Mengxing Wang N/A,Haibo Wu N/A
DOI: https://doi.org/10.1001/jamaneurol.2024.1433
2024-07-01
Abstract:Importance: Comparisons are limited for immediate-intensive and delayed-intensive statin for secondary stroke prevention and neuroprotection in patients with acute mild ischemic stroke or transient ischemic attack (TIA) from atherosclerosis. Objective: To estimate whether immediate-intensive statin therapy is safe and can lower the risk of recurrent stroke compared with delayed-intensive statin in patients with acute mild ischemic stroke or high-risk TIA from atherosclerosis. Design, setting, and participants: The Intensive Statin and Antiplatelet Therapy for High-Risk Intracranial or Extracranial Atherosclerosis (INSPIRES) trial, a double-blind, placebo-controlled, 2 × 2 factorial, randomized clinical trial enrolled patients from September 2018 to October 2022. The trial was conducted at 222 hospitals in China. Patients aged 35 to 80 years with mild ischemic stroke or high-risk TIA of presumed atherosclerosis within 72 hours of symptom onset were assessed. Interventions: Patients were randomly assigned to receive immediate-intensive atorvastatin (80 mg daily on days 1-21; 40 mg daily on days 22-90) or 3-day delayed treatment (placebo for days 1-3, followed by placebo and atorvastatin, 40 mg daily on days 4-21, and then atorvastatin, 40 mg daily on days 22-90). Main outcomes and measures: The primary efficacy outcome was new stroke within 90 days, and a secondary efficacy outcome was poor functional outcome. Moderate to severe bleeding was the primary safety outcome. Results: A total of 11 431 patients were assessed for eligibility, and 6100 patients (median [IQR] age, 65 [57-71] years; 3915 men [64.2%]) were enrolled, with 3050 assigned to each treatment group. Within 90 days, new stroke occurred in 245 patients (8.1%) in the immediate-intensive statin group and 256 patients (8.4%) in the delayed group (hazard ratio, 0.95; 95% CI, 0.80-1.13). Poor functional outcome occurred in 299 patients (9.8%) and 348 patients (11.4%) in the immediate-intensive and delayed-intensive statin groups, respectively (odds ratio, 0.83; 95% CI, 0.71-0.98). Moderate to severe bleeding occurred in 23 of 3050 patients (0.8%) and 17 of 3050 patients (0.6%), in the immediate-intensive and delayed-intensive statin groups, respectively. Conclusions and relevance: Immediate-intensive statin initiated within 72 hours did not reduce the risk of stroke within 90 days and may be associated with improved functional outcomes without significant difference in moderate to severe bleeding, compared with 3-day delayed-intensive statin in Chinese patients with acute mild ischemic stroke or TIA from atherosclerosis. Trial registration: ClinicalTrials.gov Identifier: NCT03635749.